Allo BMT in Advanced Leukemia or High Grade Lymphoma

Not Recruiting

Trial ID: NCT00186290

Age - N/A-50 Years Condition - Blood and Marrow Transplant (BMT), Leukemia, Lymphomas: Non-Hodgkin Gender - All Accepting Healthy Volunteers - No

Purpose

To evaluate the role of ablative allogeneic hematopoietic cell transplantation in the treatment of advanced leukemia or lymphoma.

Official Title

Fractionated Total Body Irradiation (FTBI), Etoposide (VP-16) and Cyclophosphamide (CY) Followed by Allogeneic Bone Marrow Transplantation for Patients With Advanced Leukemia or High Grade Lymphoma

Stanford Investigator(s)

Robert Lowsky
Robert Lowsky

Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

Laura Johnston
Laura Johnston

Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

Robert Negrin
Robert Negrin

Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

Eligibility


Inclusion Criteria:HLA identical donor

   - adequate organ function

   - other life threatening disease

View More
View Less

Intervention(s):

procedure: ablative allogeneic hematopoietic cell transplantation

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
BMT Referrals
6507230822

New Trial Alerts

©2024 Stanford Medicine